SCHEMBL844924

SCHEMBL844924

CC(C)(C)OCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL237181 0.78 MAPK1 (0.40)
SCHEMBL25590971 0.77
SCHEMBL194152 0.73
SCHEMBL9748339 0.73
SCHEMBL10717480 0.72 MAPK1 (0.36)
SCHEMBL16889090 0.72
SCHEMBL10932413 0.72 MAPK1 (0.36)
SCHEMBL27267791 0.69
SCHEMBL19193963 0.69 MAPK1 (0.35)
SCHEMBL239368 0.69 MAPK1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067457-A1 HETEROCYCLIC FUSED RING COMPOUND, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2025-04-03 WO disclosed
CN-111410607-B Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same 浙江九洲药业股份有限公司 2023-05-09 CN disclosed
CN-106496263-B Process for producing hexahydrofurofuranol derivative, intermediate therefor, and process for producing the intermediate 浙江九洲药业股份有限公司 2020-10-30 CN disclosed
CN-111410607-A Process for producing hexahydrofurofuranol derivative, intermediate therefor, and process for producing the intermediate 浙江九洲药业股份有限公司 2020-07-14 CN disclosed
EP-2188276-B1 SUBSTITUTED HYDANTOINS HOFFMANN LA ROCHE (CH) 2012-03-28 EP disclosed
US-8063085-B2 Substituted hydantoins HOFFMANN-LA ROCHE INC. (US) 2011-11-22 US disclosed
EP-2234982-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
EP-2188276-A1 SUBSTITUTED HYDANTOINS F. Hoffmann-Roche AG (CH) 2010-05-26 EP disclosed
CN-100537575-C Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof SUMITOMO CHEMICAL CO (JP) 2009-09-09 CN disclosed
US-7557221-B2 Substituted hydantoins HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-5686624-A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present SANOFI (FR) 1997-11-11 US disclosed
US-5663431-A CHEMICAL INTERMEDIATES SANOFI (FR) 1997-09-02 US disclosed
US-5594006-A SUCH AS COLLEGENASE, STROMELYSIN; ANTICANCER AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 US disclosed
US-5576324-A Quinoline derivatives or salt thereof and remedy for cardiac diseases containing the same KOWA CO., LTD. (JP) 1996-11-19 US disclosed
CN-1107467-A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present SANOFI SA (FR) 1995-08-30 CN disclosed
CN-1105799-A Carbostyril derivatives as matrix metalloproteinases inhibitors OTSUKA PHARMA CO LTD (JP) 1995-07-26 CN disclosed
EP-0641323-A1 CARBOSTYRIL DERIVATIVES AS MATRIX METALLOPROTEINASES INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-03-08 EP disclosed
EP-0638571-A1 QUINOLINE DERIVATIVE OR SALT THEREOF AND REMEDY FOR CARDIAC DISEASES CONTAINING THE SAME KOWA CO. LTD. (JP) 1995-02-15 EP disclosed
EP-0636608-A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them SANOFI (FR) 1995-02-01 EP disclosed
WO-1994021612-A1 CARBOSTYRIL DERIVATIVES AS MATRIX METALLOPROTEINASES INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-09-29 WO disclosed